Logo image of GBL

GAMCO INVESTORS INC-A (GBL) Stock Fundamental Analysis

NYSE:GBL - New York Stock Exchange, Inc. - US3614381040 - Common Stock - Currency: USD

14.78  -1.32 (-8.2%)

After market: 14.75 -0.03 (-0.2%)

Fundamental Rating

1

Overall GBL gets a fundamental rating of 1 out of 10. We evaluated GBL against 225 industry peers in the Capital Markets industry. GBL has a bad profitability rating. Also its financial health evaluation is rather negative. GBL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

GBL had positive earnings in the past year.
GBL Yearly Net Income VS EBIT VS OCF VS FCFGBL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M

1.2 Ratios

Industry RankSector Rank
ROA 33.31%
ROE 62.36%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GBL Yearly ROA, ROE, ROICGBL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 200 400 600 800 1K

1.3 Margins

Industry RankSector Rank
OM 42.47%
PM (TTM) 25.58%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GBL Yearly Profit, Operating, Gross MarginsGBL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 20 40 60 80

1

2. Health

2.1 Basic Checks

GBL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GBL has less shares outstanding
GBL has a worse debt/assets ratio than last year.
GBL Yearly Shares OutstandingGBL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M
GBL Yearly Total Debt VS Total AssetsGBL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

A Debt/Equity ratio of 0.28 indicates that GBL is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.74%
GBL Yearly LT Debt VS Equity VS FCFGBL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M -100M 200M -200M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

2

3. Growth

3.1 Past

GBL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.86%, which is quite good.
The Earnings Per Share has been growing by 11.02% on average over the past years. This is quite good.
The Revenue has been growing slightly by 6.04% in the past year.
Measured over the past years, GBL shows a decrease in Revenue. The Revenue has been decreasing by -3.13% on average per year.
EPS 1Y (TTM)8.86%
EPS 3Y9.25%
EPS 5Y11.02%
EPS Q2Q%3.18%
Revenue 1Y (TTM)6.04%
Revenue growth 3Y-4.11%
Revenue growth 5Y-3.13%
Sales Q2Q%-13.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GBL Yearly Revenue VS EstimatesGBL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M
GBL Yearly EPS VS EstimatesGBL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

GBL is valuated cheaply with a Price/Earnings ratio of 5.26.
Compared to an average S&P500 Price/Earnings ratio of 29.62, GBL is valued rather cheaply.
Industry RankSector Rank
PE 5.26
Fwd PE N/A
GBL Price Earnings VS Forward Price EarningsGBL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.31
GBL Per share dataGBL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.48
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.94%, GBL is not a good candidate for dividend investing.
The stock price of GBL dropped by -30.18% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
With a Dividend Yield of 0.94, GBL pays less dividend than the S&P500 average, which is at 2.27.
Industry RankSector Rank
Dividend Yield 0.94%

5.2 History

GBL has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
GBL Yearly Dividends per shareGBL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 0.5 1 1.5 2

5.3 Sustainability

GBL pays out 6.43% of its income as dividend. This is a sustainable payout ratio.
DP6.43%
EPS Next 2YN/A
EPS Next 3YN/A
GBL Yearly Income VS Free CF VS DividendGBL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
GBL Dividend Payout.GBL Dividend Payout, showing the Payout Ratio.GBL Dividend Payout.PayoutRetained Earnings

GAMCO INVESTORS INC-A

NYSE:GBL (10/6/2022, 8:04:00 PM)

After market: 14.75 -0.03 (-0.2%)

14.78

-1.32 (-8.2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-16 2022-08-16/amc
Earnings (Next)11-03 2022-11-03/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners11.24%
Ins Owner Change0%
Market Cap390.11M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.94%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP6.43%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.26
Fwd PE N/A
P/S 1.33
P/FCF N/A
P/OCF N/A
P/B 3.25
P/tB N/A
EV/EBITDA 2.31
EPS(TTM)2.81
EY19.01%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS11.09
BVpS4.55
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.48
Profitability
Industry RankSector Rank
ROA 33.31%
ROE 62.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 42.47%
PM (TTM) 25.58%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.86%
EPS 3Y9.25%
EPS 5Y11.02%
EPS Q2Q%3.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.04%
Revenue growth 3Y-4.11%
Revenue growth 5Y-3.13%
Sales Q2Q%-13.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A